VTVT
Price
$35.28
Change
-$1.54 (-4.18%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
146.28M
47 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$4.06
Change
+$0.27 (+7.12%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
269.08M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

VTVT vs ZNTL

VTVT vs ZNTL Comparison Chart in %
View a ticker or compare two or three
VS
VTVT vs. ZNTL commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTVT is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (VTVT: $37.14 vs. ZNTL: $3.78)
Brand notoriety: VTVT and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VTVT: 160% vs. ZNTL: 98%
Market capitalization -- VTVT: $146.28M vs. ZNTL: $269.08M
VTVT [@Biotechnology] is valued at $146.28M. ZNTL’s [@Biotechnology] market capitalization is $269.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTVT’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • VTVT’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both VTVT and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTVT’s TA Score shows that 5 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • VTVT’s TA Score: 5 bullish, 3 bearish.
  • ZNTL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VTVT is a better buy in the short-term than ZNTL.

Price Growth

VTVT (@Biotechnology) experienced а +5.99% price change this week, while ZNTL (@Biotechnology) price change was +2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.28%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +1924.65%.

Reported Earning Dates

VTVT is expected to report earnings on Aug 12, 2026.

ZNTL is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+7.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZNTL($269M) has a higher market cap than VTVT($146M). ZNTL YTD gains are higher at: 180.000 vs. VTVT (-7.127). VTVT has higher annual earnings (EBITDA): -1.3M vs. ZNTL (-144.41M). ZNTL has more cash in the bank: 212M vs. VTVT (98.1M). VTVT has less debt than ZNTL: VTVT (360K) vs ZNTL (34.6M). VTVT has higher revenues than ZNTL: VTVT (36.8M) vs ZNTL (0).
VTVTZNTLVTVT / ZNTL
Capitalization146M269M54%
EBITDA-1.3M-144.41M1%
Gain YTD-7.127180.000-4%
P/E RatioN/AN/A-
Revenue36.8M0-
Total Cash98.1M212M46%
Total Debt360K34.6M1%
FUNDAMENTALS RATINGS
VTVT vs ZNTL: Fundamental Ratings
VTVT
ZNTL
OUTLOOK RATING
1..100
319
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8799
PRICE GROWTH RATING
1..100
4435
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZNTL's Valuation (18) in the null industry is in the same range as VTVT (19) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to VTVT’s over the last 12 months.

ZNTL's Profit vs Risk Rating (100) in the null industry is in the same range as VTVT (100) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to VTVT’s over the last 12 months.

VTVT's SMR Rating (87) in the Biotechnology industry is in the same range as ZNTL (99) in the null industry. This means that VTVT’s stock grew similarly to ZNTL’s over the last 12 months.

ZNTL's Price Growth Rating (35) in the null industry is in the same range as VTVT (44) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to VTVT’s over the last 12 months.

ZNTL's P/E Growth Rating (100) in the null industry is in the same range as VTVT (100) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to VTVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VTVTZNTL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
VTVT
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRGVX57.120.57
+1.01%
BNY Mellon Dynamic Value Fund I
BIAGX9.49N/A
N/A
Brown Advisory Growth Equity Inv
TSHIX16.52N/A
N/A
Transamerica Multi-Asset Income I
GRESX9.23N/A
N/A
Goldman Sachs Real Estate Securities Svc
JGSMX27.96N/A
N/A
JPMorgan Small Cap Growth R6

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with VCYT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-4.79%
VCYT - ZNTL
39%
Loosely correlated
+3.22%
MLTX - ZNTL
38%
Loosely correlated
+0.05%
LPCN - ZNTL
38%
Loosely correlated
-3.64%
TIL - ZNTL
35%
Loosely correlated
-2.03%
EDIT - ZNTL
35%
Loosely correlated
-2.14%
More